Recently, the conclusions of the Cochrane analysis has been debated. It has been argued that the evidence of effectiveness/equivalence is based on studies where oral misoprostol has been used in high dosages (>25 mcg), whereas the studies that concluded an increased risk of complications, used small dosages.